Day 1 – Thursday, June 20, 2024
Keynote Speech 2024: Phage Therapeutics 2024: The Critical Role of Translational Research in Clinical Trials |
Robert T. Schooley, University of California, San Diego, USA |
Session 1: Phages, Hosts & Microbiome: On the Way to Medical Revolution |
Eugene V Koonin, National Institutes of Health, USA |
Wolfgang Weninger, Medical University of Vienna, Austria |
Jumpei Fujiki, University of California San Diego, USA |
Domenico Frezza, University of Roma Tor Vergata, Italy |
Session 2 – Phage Therapy: Emerging Trends and Innovative Approaches |
Graham F. Hatfull, University of Pittsburgh, USA |
Paul Turner, Yale University, USA |
Antonia P. Sagona, University of Warwick, United Kingdom
|
Rodrigo Ibarra Chavez, University of Copenhagen, Denmark |
Day 2 – Friday, June 21, 2024
Session 3: Phages Therapy 2024: From Bench to Bedside |
Nannan Wu, Shanghai Public Health Clinical Center, Fudan University, China |
Sabrina Green, KU Leuven, Belgium |
Federica Briani, University of Milan, Italy |
Session 4: Ethical Considerations and Regulatory Landscape of Phage Therapy: Challenges, Advocacy and Task Forces |
Barbara Brenner, Kanzlei BRENNER, Germany |
Jean-Paul Pirnay, Queen Astrid Military Hospital, Belgium
|
Pieter-Jan Ceyssens, Sciensano, Belgium |
Phage Therapy 2024 Concluding Remarks |
Phage Therapy 2024 Awards: |
End of Targeting Phage Therapy 2024 |